Fig. 1From: Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia a Cumulative incidence of non-relapse mortality (NRM); b cumulative incidence of relapse (CIR); c leukemia-free survival (LFS); and d survival of subjects with and without IKZF1 deletion since first complete remissionBack to article page